CQDM

HOME
ABOUT
PROGRAMS
FUNDED PROJECTS
NEWS
Contact
FR
SPECIAL INITIATIVES
- FACS
- CATALIS

HOME
ABOUT
PROGRAMS
FUNDED PROJECTS
NEWS
Contact
FR
SPECIAL INITIATIVES
- FACS
- CATALIS

Our Latest News

We are RECRUITING ! Interested in a Senior Director, Business Development position ? Apply now !
19 July 2019
Amgen and Takeda join the Quantum Leap project led by CQDM and Feldan Therapeutics
4 June 2019
Contribution from the MEI ($3.3M) allows CQDM to support 5 biopharmaceutical research projects ($15.5M)
4 June 2019
The CCS, CQDM and biotech companies will invest nearly $10M to support 3 breast cancer research projects
1 June 2019
CQDM, Diazon and the Oncopole in collaboration with Mitacs announce the two laureates of the 2019 Gordon Shore Prize
23 May 2019
Hope on the horizon for hard-to-treat breast cancers
14 May 2019
CQDM, HBHL, Corbin Therapeutics and Brain Canada award $1.5 M to McGill Prof. Philippe Gros
2 May 2019
We are RECRUITING! Interested in a Project Coordinator position? Apply now!
29 April 2019
We are RECRUITING! Interested in a Artificial Intelligence Project Manager position? Apply now!
26 April 2019
IMV and CRCHU de Québec-U Laval Collaboration Awarded a CQDM Grant to Develop First-in-class Dual Target T cell Therapy in Bladder Cancer Based on IMV’s DPX Technology
18 March 2019
Call for Applications for the Gordon Shore Prize – Internships for new graduates
21 February 2019
Philippe Walker appointed Member of the Scientific Advisory Board of CQDM
29 January 2019
Call for Proposal to Private Companies – Post-Diploma Internships Co-Funded through the Gordon Shore Prize
9 January 2019
Merck Canada reaffirms its commitment to CQDM with a $3.5M contribution to sustain innovation in Life Sciences
19 November 2018
Pfizer Canada renews its support to CQDM with a $550,000 contribution
19 November 2018
Amgen becomes a new member of CQDM to further the development of cutting-edge drug discovery
19 November 2018
CQDM, Diazon and the Oncopole in collaboration with Mitacs announce the creation of a prize of excellence for graduate students in cancer research in memory of Professor Gordon Shore
19 November 2018
Les regroupements sectoriels de recherche industrielle offrent leurs félicitations au nouveau ministre de l’Économie et de l’Innovation
19 October 2018
CQDM is proud to be part of Optina Diagnostics’ success
12 October 2018
(FR) CQDM sera à Québec le 10 octobre pour présenter ses programmes de financement
28 September 2018
We are RECRUITING! Interested in a Controller position? Apply now!
27 July 2018
CQDM SynergiQc program now includes an additional section on breast cancer, in collaboration with the Canadian Cancer Society
19 July 2018
Canadian Cancer Society and CQDM announce a partnership of $5 million for breast cancer research in Quebec
20 June 2018
CQDM to support a $1.1 M R&D project for Immune Biosolutions’ next-generation of anti-cancer treatment
6 June 2018
CQDM welcomes two new pharma members to its biopharmaceutical research consortium
6 June 2018
CQDM will partner with Feldan Therapeutics to support a $1.2M project, to improve a novel intra-cellular delivery technology
29 May 2018
CQDM and Brain Canada Inject $1 M in Top BC Biotech Firm AbCellera to Advance Discovery Platform for Next-Generation Antibody Therapeutics
18 January 2018
Rémi Quirion joins the CQDM Board
11 December 2017
NEW PROGRAM: SYNERGIQC
23 May 2017
CQDM is recruiting! Interested in a summer Internship position in Administration and Accounting? Apply now!
11 April 2017
A research project originally funded by CQDM and Brain Canada leads to a new partnership between the Centre for Drug Research and Development (CDRD), the Montreal Neurological Institute and Hospital at McGill University (MNI), and Merck
24 March 2017
We are RECRUITING: General Director for Early Stage Clinical Trial
13 March 2017
We are RECRUITING for a Communication position: Director of Communications and Public Relations – CQDM (Deadline to apply: January 27th)
10 January 2017
Patrick Wier and Jorge Puente appointed to CQDM’s Board of Directors
24 November 2016
Ali Tehrani appointed on CQDM’s Board of Directors
19 September 2016
A project funded by CQDM redefines the treatment of cancer
25 August 2016
Six new drug discovery acceleration projects supported by CQDM and Ontario Centres of Excellence showcase continued success of Quebec-Ontario Life Sciences Corridor
7 June 2016
First research project to be funded under the Canada/Germany Program
26 May 2016
PulmoBind: A Biomarker for Diagnosing Pulmonary Hypertension
5 April 2016
CQDM’s 2015 Activity Report: A toolbox of success
22 February 2016
Richard Fajzel appointed new Chairman of CQDM’s Board of Directors
18 February 2016
Uwe Schoenbeck from Pfizer Inc. appointed member of CQDM’s Board of Directors
11 November 2015
Wallonia (Belgium) and Canada join forces in a new international initiative to improve biopharmaceutical R&D
29 October 2015
Germany and Canada join forces to enhance biopharmaceutical R&D internationally
6 October 2015
Personalized medicine: CQDM and CIHR fund two promising research collaborations aligning academic and industrial research
29 July 2015
Encycle Therapeutics working with major pharmaceutical companies to design rules for drugs meant to be swallowed
16 June 2015
$1.5M to accelerate drug discovery within the Quebec-Ontario Life Sciences Corrido
16 June 2015
Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences
26 May 2015
Michel Goldman appointed member of CQDM’s Board of Directors
15 April 2015
Quantum Leap – Program Opened
4 February 2015

Annual Archive

2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008

About CQDM

Our Mission, Vision and Impact
Structure & Governance
Team
Members
Collaborators
Contact us

Programs

Quantum Leap
SynergiQc
SynergiQc-International
Mentorship
Completed Programs

Follow Us!

Tweets by @CQDM_Canada

© CQDM 2019 // Web: Draxo Marketing

We use cookies and other tracking technologies to improve your browsing experience on our website. By browsing our website, you consent to our use of cookies and other tracking technologies. Accept